Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 1 E, F
Walentek P et al. (2013)
|
Xla Wt + wnt11b
NF31 (in situ hybridization)
|
|
|
|
Fig. S1 B, C, D, E
Walentek P et al. (2013)
|
Xla Wt + wnt11b MO
NF10-10.5 (in situ hybridization)
|
|
|
|
Fig. 4 B,C G,H
Walentek P et al. (2013)
|
Xla Wt + wnt11b MO
NF16 (in situ hybridization)
|
|
|
|
Fig. 1 E, F
Walentek P et al. (2013)
|
Xla Wt + wnt11b MO
NF31 (in situ hybridization)
|
|
|
|
fig 6.d,e
Li Y et al. (2008)
|
Xla Wt + wnt11b
NF18 (in situ hybridization)
|
|
|
|
fig 6.d,e
Li Y et al. (2008)
|
Xla Wt + wnt11b
NF35/36 (in situ hybridization)
|
|
|
|
fig 7.a
Li Y et al. (2008)
|
Xla Wt + wnt11b MO
NF18 (in situ hybridization)
|
|
|
|
fig.S7.b
Li Y et al. (2008)
|
Xla Wt + wnt11b MO
NF35/36 (in situ hybridization)
|
|
|